Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Drug delivery techniques for treating age-related macular degeneration
Stephen G. Schwartz
,
Ingrid U. Scott
, Harry W. Flynn
, Michael W. Stewart
Department of Ophthalmology
Department of Public Health Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
46
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drug delivery techniques for treating age-related macular degeneration'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Drug Delivery System
100%
Age-related Macular Degeneration
100%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
100%
Release Process
66%
Sustained Release
66%
Intravitreal Injection
66%
Reinjection
66%
Nanoparticles
33%
Drug Delivery
33%
Clinical Trials
33%
Popular
33%
Family Physicians
33%
Expert Opinion
33%
Cumulative Risk
33%
Liposomes
33%
Microparticles
33%
Bevacizumab
33%
Relative Efficacy
33%
Endophthalmitis
33%
Office-based
33%
Non-invasive Method
33%
Safety Self-efficacy
33%
Intravitreal Anti-vascular Endothelial Growth Factor Injection
33%
Ranibizumab
33%
Area Cover
33%
Neovascular Age-related Macular Degeneration (nAMD)
33%
Sustained Release Device
33%
Aflibercept
33%
Repeated Injection
33%
Patient's Family Member
33%
Number of Injections
33%
Colloidal Carriers
33%
Sustained Drug Release
33%
Pharmacology, Toxicology and Pharmaceutical Science
Sustained Release
100%
Age Related Macular Degeneration
100%
Vasculotropin
75%
Intravitreal Administration
50%
Clinical Trial
25%
Nanoparticle
25%
Liposome
25%
Bevacizumab
25%
Endophthalmitis
25%
Implant
25%
Wet Macular Degeneration
25%
Aflibercept
25%
Ranibizumab
25%
Microparticle
25%